Welcome to our dedicated page for SHF Holdings SEC filings (Ticker: SHFSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SHF Holdings, Inc. SHFSW SEC filings page brings together the company’s regulatory disclosures, including documents that describe its Nasdaq-listed redeemable warrants and related capital arrangements. SHFSW denotes the redeemable warrants of SHF Holdings, Inc., with each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share, as disclosed in an 8-K filing.
In its 8-K, SHF Holdings, Inc. reports entering into a Common Stock Purchase Agreement with CREO Investments LLC. This filing outlines the conditions under which the company may sell Class A common stock to CREO, the definition of the VWAP Purchase Price, the exchange cap based on Nasdaq rules, and several automatic termination events. The same filing describes a related registration rights agreement covering the resale of common stock issued under the purchase agreement and notes that net proceeds are expected to be used for working capital and general corporate purposes.
On this page, users can review such 8-Ks and other SEC documents to understand how SHF Holdings, Inc. structures its financing arrangements, how SHFSW is defined, and how regulatory requirements are reflected in formal disclosures. Filings may also reference the company’s focus on financial services for cannabis-related businesses and its emphasis on Bank Secrecy Act obligations and FinCEN guidance.
Stock Titan enhances access to these filings with AI-powered summaries that explain key terms, highlight important clauses, and clarify complex sections of documents such as 8-Ks, 10-Ks, and 10-Qs. Real-time updates from EDGAR, along with structured views of forms like Form 4 for insider transactions when available, help users quickly locate and interpret information relevant to SHF Holdings, Inc. and its SHFSW warrants.
SHF Holdings, Inc. entered into a Common Stock Purchase Agreement with CREO Investments LLC allowing the company to sell up to the lesser of $150,000,000 of Class A common stock or 582,899 shares, which represents 19.99% of shares outstanding immediately before signing, until any required stockholder approval is obtained. The agreement functions as an equity financing facility under which SHF can, at its discretion, direct CREO to buy shares over a period of up to 36 months at a price equal to 90% of the lower of the stock’s lowest sale price or volume-weighted average price on specified trading days.
The total purchase commitment may be increased by mutual agreement up to an aggregate of $500,000,000, with SHF issuing additional preferred "CREO Commitment Shares" equal to 0.75% of each $100,000,000 increase. SHF will also issue $1.0 million in stated value of a new series of preferred stock to CREO as consideration for its commitment and has agreed to register the resale of shares issued under the arrangement. The company states it expects to use any net proceeds for working capital and general corporate purposes, subject to Nasdaq’s 19.99% exchange cap unless stockholders approve issuances above that threshold.
SHF Holdings, Inc. reporting person Terrance Elliot Mendez, who serves as a director, CEO and interim CFO, disclosed receipt of a stock option on 08/07/2025. The option covers 91,751 shares of common stock with an exercise price of $2.40 per share and shows 91,751 shares beneficially owned following the transaction in a direct capacity. The option has an expiration/exercisable reference of 08/06/2035 and vests 100% only upon the issuer completing an equity financing that raises at least $4 million. The Form 4 is signed by Mr. Mendez on 09/17/2025.
Insider grant vested and became exercisable: Francis A. Braun III, a director of SHF Holdings, Inc. (ticker shown as SHFS in the filing), had a stock option that vested 100% on August 7, 2025. The option covers 53,144 underlying shares with an exercise price of $2.40 per share and an expiration date of August 6, 2035. Following the reported transaction the filing shows 53,114 shares beneficially owned directly.
The filing is a Form 4 reporting an individual (one reporting person) exercise-right acquisition event for an insider director. The signature block shows the report was signed on September 17, 2025. No cash exercise or sale of shares is reported in this Form 4; it documents the vesting and resulting beneficial ownership and the terms of the derivative (option).
FAQ
What is the current stock price of SHF Holdings (SHFSW)?
